External Evaluation For US FDA Food Safety ‘Structure, Function, Funding and Leadership’
Members of Congress won’t find mention of criticism of FDA food safety oversight linked most recently to infant formula shortage in Commissioner Califf's announcement. He also didn’t refer to the formula shortage.
You may also be interested in...
Cosmetics and dietary supplement program reforms may have to wait if Republican Sen. Burr's stripped-down version of US FDA user-fee reauthorization package – which tracks with companion legislation already passed in the House – is the best Congress can do before the August recess.
First-term Iowa Republican Hinson had support from Democrat as well as other GOP members for withholding part of commissioner office’s FY2023 budget. Opposition from a self-acknowledged unlikely source, committee chair DeLauro, steered votes toward rejecting the proposal.
HELP Committee passes five-year reauthorization of FDA drug, medical device and biosimilar user fees with separate provisions expanding agency’s authority to regulate infant formula manufacturing and marketing and establishing Office of Critical Foods in CFSAN.